FeesSafety
Pluang+

Century Therapeutics advances diabetes and autoimmune therapies, targets clinical trials in 2026-27 with strong cash runway.

Company Fundamentals
12 Nov 2026, 14:05 WIB
GlobeNewsWire
View Source
Bullish
Century Therapeutics advances diabetes and autoimmune therapies, targets clinical trials in 2026-27 with strong cash runway.

Century Therapeutics reported Q3 2026 results highlighting progress on its iPSC-derived therapies for type 1 diabetes and autoimmune diseases. The company plans to submit an IND for CNTY-813, a potential functional cure for type 1 diabetes, in Q4 2026, with initial clinical data expected in the second half of 2027. Additionally, CNTY-308, a CAR-iT cell therapy, is set to enter clinical trials in 2026. Century holds $174.1 million in cash and investments, supporting operations into early 2029, positioning it well for upcoming clinical milestones.

Century Therapeutics' Q3 2026 update comes amid a health sector market where 84 of 150 US stocks rose and 57 fell on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 12, 2026 18:11 WIB: BIO-TECHNE Corp (TECH) traded at USD 71.00 with a 1-day change of -2.47% and 100% buy order activity, Hims and Hers Health Inc (HIMS) at USD 20.32 with -2.35% change and 82% sell order activity, and Nuwellis Inc (NUWE) at USD 5.66 with +2.35% change and 100% sell order activity. Typical hold times ranged from 24 to 65 days among these movers.

More News

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
50 minutes ago
Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....

Company Fundamentals
Bullish
1 hour ago
Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
1 hour ago
Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...

Company Fundamentals
Neutral
1 hour ago
Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App